Addition of sunitinib to cetuximab and irinotecan in patients with heavily pre-treated advanced colorectal cancer

By Qvortrup Camilla   Jensen Benny Vittrup   Jorgensen Trine Lembrecht   Nielsen Dorte   Bjerregaard Jon Kroll   Pfeiffer Per  

Acta Oncologica, Vol. 49, Iss. 6, 2010-08 ,pp. : 833-836

Informa Healthcare

Access to resources Recommend Favorite

Weekly irinotecan (CPT-11) in 5-FU heavily pretreated and poor-performance-status patients with advanced colorectal cancer

By Benavides M.   García-Alfonso P.   Cobo M.   Muñoz-Martín A.   Gil-Calle S.   Carabantes F.   Villar E.   Graupera J.   Balcells M.   Pérez-Manga G.  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 255-262

Humana Press, Inc

Access to resources Recommend Favorite

Salvage Therapy with Capecitabine Plus Weekly Paclitaxel in Heavily Pretreated Advanced Breast Cancer: A Multicenter Phase II Study

By Bari Mario  

American Journal of Cancer, Vol. 4, Iss. 5, 2005-01 ,pp. : 307-313

Adis International

Access to resources Recommend Favorite

Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer

By Osako Tomo   Ito Yoshinori   Takahashi Shunji   Tokudome Nahomi   Iwase Takuji   Hatake Kiyohiko  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 159-164

Springer Publishing Company

Access to resources Recommend Favorite

Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer

By Bartsch Rupert   Wenzel Catharina   Gampenrieder Simon   Pluschnig Ursula   Altorjai Gabriela   Rudas Margaretha   Mader Robert   Dubsky Peter   Rottenfusser Andrea   Gnant Michael   Zielinski Christoph   Steger Guenther  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 5, 2008-10 ,pp. : 903-910

Springer Publishing Company

Access to resources Recommend Favorite